What Makes a Home Health Care Business Worth More?

Home health agencies with CMS 4.5+ star ratings, diversified payor mix across Medicare/Medicaid/private pay, and caregiver turnover below 50% can command a 1.5x multiple premium — moving deals from 5x-6x EBITDA for average agencies to 7.5x-9.5x EBITDA for premium operators. Scale matters too: agencies under $500K EBITDA trade at 3.5x-5x, while platforms above $5M EBITDA can reach 8x+.

Typical Range: 3.5x-9.5x EBITDA | Premium Driver: CMS Star Rating + Payor Mix + Retention | Sweet Spot: $3M-$20M Revenue, Medicare Certified

What Specifically Drives a Premium Multiple?

Five factors separate premium home health agencies from average ones. First, CMS star ratings — agencies at 4.5 or 5 stars in Quality of Patient Care signal lower regulatory risk and command the 1.5x premium that buyers repeatedly pay for. Second, payor mix diversification — a mix of roughly 40% Medicare, 30% Medicaid, and 30% private pay/commercial gets credit that a Medicare-only agency doesn't, because buyers see durable revenue across reimbursement shifts. Third, caregiver turnover — the industry average runs 60-80% annually, and agencies below 50% command premium pricing because turnover is the operational choke point in home health. Fourth, outcomes and readmissions data — agencies that can show documented reductions in 30-day hospital readmissions are being valued for what they deliver clinically, not just what they bill. Fifth, scale and scalability — multi-location agencies with shared services infrastructure and clinical leadership independent of the owner scale cleanly for a buyer.

Buyers in 2026 include Enhabit, BrightSpring Health Services, Addus HomeCare, LHC Group (owned by UnitedHealth's Optum), Amedisys, and Aveanna Healthcare on the strategic side, plus PE-backed platforms from Webster Equity Partners, H.I.G. Capital, Nautic Partners, and Vistria Group. Regional buyers are increasingly active too — I track over 40 regional platforms in the Southeast and Mid-Atlantic alone. For more detail on how buyers evaluate agencies, see the home health hub. Agencies often find the same quality-of-earnings scrutiny applied to adjacent care businesses like hospice operators, where clinical outcomes, compliance, and caregiver retention drive identical premium dynamics.

"I had two home health sellers last year with nearly identical EBITDA — about $1.4M each. One sold at 8x, the other at 5x. The difference came down to three numbers: the 8x seller ran a 5-star CMS rating, 44% caregiver turnover, and a 55/25/20 Medicare/Medicaid/private-pay mix. The 5x seller had a 3.5-star rating, 72% turnover, and was 95% Medicare. Same industry, same region, same size. Three operational numbers. $4.2M difference in enterprise value."

— John M. Salony, Business Broker

Find Out What Your Home Health Care Business Is Worth

Start with the free valuation calculator to benchmark your agency against premium-multiple operators, then schedule a confidential consultation to walk through which levers would move your multiple the most.

Schedule a Confidential Consultation

Frequently Asked Questions

What Specifically Drives a Premium Multiple?
Five factors separate premium home health agencies from average ones. First, CMS star ratings — agencies at 4.5 or 5 stars in Quality of Patient Care signal lower regulatory risk and command the 1.5x premium that buyers repeatedly pay for. Second, payor mix diversification — a mix of roughly 40% Medicare, 30% Medicaid, and 30% private pay/commercial gets credit that a Medicare-only agency doesn't, because buyers see durable revenue across reimbursement shifts. Third, caregiver turnover — the industry average runs 60-80% annually, and agencies below 50% command premium pricing because turnover is the operational choke point. Fourth, outcomes and readmissions data — agencies that can show documented reductions in 30-day hospital readmissions are being valued for clinical delivery, not just billing. Fifth, scale and scalability — multi-location agencies with shared services infrastructure and clinical leadership independent of the owner scale cleanly.
Who Is Buying Premium Home Health Agencies?
Strategic buyers in 2026 include Enhabit, BrightSpring Health Services, Addus HomeCare, LHC Group (owned by UnitedHealth's Optum), Amedisys, and Aveanna Healthcare. On the private equity side, active platforms include Webster Equity Partners, H.I.G. Capital, Nautic Partners, and Vistria Group, plus over 40 regional PE-backed rollups operating in the Southeast and Mid-Atlantic. Each buyer has a different appetite — national strategics focus on Medicare-certified agencies with $5M+ revenue and clean OASIS data, while regional PE platforms look for $1M-$5M EBITDA tuck-ins they can integrate into existing clinical infrastructure. Private-pay focused home care operators like Home Helpers, Right at Hand, and BrightStar are also acquiring, targeting non-skilled personal care agencies with strong caregiver retention and established referral relationships with hospital discharge planners.